Biomarker in liquid biopsy for lung cancer appears more accurate in predicting immunotherapy response than tumor biopsy

Mount Sinai researchers have validated for the first time that a simple blood test called a liquid biopsy could be a better predictor of whether cancer immunotherapy will be successful for a patient with lung cancer than an invasive tumor biopsy procedure. Their study was published in the Journal of Experimental & Clinical Cancer Research in June.

source https://medicalxpress.com/news/2022-06-biomarker-liquid-biopsy-lung-cancer.html